Subgroup analyses in randomized clinical trials: value and limitations. Review #3 on important aspects of randomized clinical trials in cardiovascular pharmacotherapy

Saved in:
Bibliographic Details
Published in:European heart journal. Cardiovascular pharmacotherapy 2022-05, Vol.8 (3), p.302-310
Main Authors: Drexel, Heinz, Pocock, Stuart J, Lewis, Basil S, Saely, Christoph H, Kaski, Juan Carlos, Rosano, Giuseppe M C, Tautermann, Gerda, Huber, Kurt, Dopheide, Joern F, Mader, Arthur, Niessner, Alexander, Savarese, Gianluigi, Schmidt, Thomas A, Semb, Anne Grete, Tamargo, Juan, Wassmann, Sven, Clodi, Martin, Kjeldsen, Keld Per, Agewall, Stefan
Format: Article
Language:English
Subjects:
Cardiology
Cardiovascular disease
Cardiovascular System
Clinical trials
Drug therapy
Evidence-based medicine
Hospitals
Humans
Medicin och hälsovetenskap
Medicine
Product development
Randomized Controlled Trials as Topic
Statistical methods
Ticagrelor
Working groups
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2055-6837
2055-6845
2055-6845
DOI:10.1093/ehjcvp/pvab048